The study included two years of data from 268 patients across three hospitals in Greece. Patients received epinephrine and either vasopressin or a placebo during CPR. Patients who received vasopressin had an 83.9 percent probability of returning to spontaneous circulation compared to the 65.9 percent probability of returning to spontaneous circulation of the other group.
In addition, 13.1 percent of patients who received vasopressin were alive and had a favorable neurological recovery compared to just 5.1 percent of patients in the control group.
More Articles on Quality:
6 Steps to Lower Heart Failure Readmissions
Reducing Preventable Birth Injuries Through Evidence-Based Care, Enhanced Teamwork
Infographic: Communication Gaps From Outdated Technology Pose Threats, Costs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.